Multiple Assemblies exist for SMTL entry 5b25
Crystal structure of human PDE1B with inhibitor 3; X-RAY DIFFRACTION 1.90 Å

	SMTL ID 5b25.1 Ligands ZINC ION; MAGNESIUM ION; (11R,15S)-4-{[4-(6-fluoropyridin-2-yl)phenyl]methyl}-8-methyl-5-(phenylamino)-1,3,4,8,10-pentaazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one; SULFATE ION; GLYCEROL Polypeptides Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B Oligo-state monomer
	SMTL ID 5b25.2 Ligands ZINC ION; MAGNESIUM ION; (11R,15S)-4-{[4-(6-fluoropyridin-2-yl)phenyl]methyl}-8-methyl-5-(phenylamino)-1,3,4,8,10-pentaazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one; SULFATE ION; GLYCEROL Polypeptides Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B Oligo-state monomer
	SMTL ID 5b25.3 Ligands ZINC ION; MAGNESIUM ION; (11R,15S)-4-{[4-(6-fluoropyridin-2-yl)phenyl]methyl}-8-methyl-5-(phenylamino)-1,3,4,8,10-pentaazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one; SULFATE ION; GLYCEROL Polypeptides Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B Oligo-state monomer
	SMTL ID 5b25.4 Ligands ZINC ION; MAGNESIUM ION; (11R,15S)-4-{[4-(6-fluoropyridin-2-yl)phenyl]methyl}-8-methyl-5-(phenylamino)-1,3,4,8,10-pentaazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one; SULFATE ION; GLYCEROL Polypeptides Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B Oligo-state monomer